Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1147514513 | 11475145 | 13 | F | 20130603 | 20160804 | 20150908 | 20160808 | EXP | CA-ROCHE-1188683 | ROCHE | 29.02 | YR | F | Y | 70.00000 | KG | 20160808 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1147514513 | 11475145 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2027B19,B2043B17,B20172,B20142,B20 | 125276 | 260 | MG | SOLUTION FOR INFUSION | |||||||
1147514513 | 11475145 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2027B19,B2043B17,B20172,B20142,B20 | 125276 | 540 | MG | SOLUTION FOR INFUSION | |||||||
1147514513 | 11475145 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2027B19,B2043B17,B20172,B20142,B20 | 125276 | 560 | MG | SOLUTION FOR INFUSION | |||||||
1147514513 | 11475145 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2027B19,B2043B17,B20172,B20142,B20 | 125276 | 540 | MG | SOLUTION FOR INFUSION | |||||||
1147514513 | 11475145 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2027B19,B2043B17,B20172,B20142,B20 | 125276 | 560 | MG | SOLUTION FOR INFUSION | |||||||
1147514513 | 11475145 | 6 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | N34931 | 103705 | 1000 | MG | SOLUTION FOR INFUSION | ||||||
1147514513 | 11475145 | 7 | SS | PNEUMOCOCCAL VACCINE POLYVALENT NOS | PNEUMOCOCCAL VACCINE POLYVALENT | 1 | Unknown | U | 0 | ||||||||||
1147514513 | 11475145 | 8 | SS | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
1147514513 | 11475145 | 9 | C | CELEBREX | CELECOXIB | 1 | 0 | ||||||||||||
1147514513 | 11475145 | 10 | C | DESOGESTREL AND ETHINYL ESTRADIOL | DESOGESTRELETHINYL ESTRADIOL | 1 | 0 | ||||||||||||
1147514513 | 11475145 | 11 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | 0 | ||||||||||||
1147514513 | 11475145 | 12 | C | BRICANYL | TERBUTALINE SULFATE | 1 | 0 | ||||||||||||
1147514513 | 11475145 | 13 | C | PULMICORT TURBUHALER | BUDESONIDE | 1 | 0 | ||||||||||||
1147514513 | 11475145 | 14 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | 0 | ||||||||||||
1147514513 | 11475145 | 15 | C | DIPHENHYDRAMINE HCL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | |||||||||
1147514513 | 11475145 | 16 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 0 | 650 | MG | |||||||||
1147514513 | 11475145 | 17 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 0 | 100 | MG | |||||||||
1147514513 | 11475145 | 18 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 0 | 650 | MG | |||||||||
1147514513 | 11475145 | 19 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | |||||||||
1147514513 | 11475145 | 20 | C | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous (not otherwise specified) | 0 | 100 | MG | |||||||||
1147514513 | 11475145 | 21 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
1147514513 | 11475145 | 22 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
1147514513 | 11475145 | 1 | Rheumatoid arthritis |
1147514513 | 11475145 | 6 | Rheumatoid arthritis |
1147514513 | 11475145 | 7 | Product used for unknown indication |
1147514513 | 11475145 | 8 | Bacterial vaginosis |
1147514513 | 11475145 | 15 | Premedication |
1147514513 | 11475145 | 16 | Premedication |
1147514513 | 11475145 | 17 | Premedication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
1147514513 | 11475145 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
1147514513 | 11475145 | Acne | |
1147514513 | 11475145 | Arthralgia | |
1147514513 | 11475145 | Arthropod bite | |
1147514513 | 11475145 | Bacterial vaginosis | |
1147514513 | 11475145 | Blood pressure diastolic decreased | |
1147514513 | 11475145 | Body temperature decreased | |
1147514513 | 11475145 | Cellulitis | |
1147514513 | 11475145 | Cough | |
1147514513 | 11475145 | Drug ineffective | |
1147514513 | 11475145 | Hypotension | |
1147514513 | 11475145 | Infusion related reaction | |
1147514513 | 11475145 | Ingrown hair | |
1147514513 | 11475145 | Injection related reaction | |
1147514513 | 11475145 | Lower respiratory tract infection | |
1147514513 | 11475145 | Neutropenia | |
1147514513 | 11475145 | Pain | |
1147514513 | 11475145 | Rash | |
1147514513 | 11475145 | Skin disorder | |
1147514513 | 11475145 | Subcutaneous abscess | |
1147514513 | 11475145 | Therapeutic response decreased | |
1147514513 | 11475145 | Upper-airway cough syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
1147514513 | 11475145 | 1 | 20130312 | 0 | ||
1147514513 | 11475145 | 2 | 20130730 | 0 | ||
1147514513 | 11475145 | 3 | 20150528 | 0 | ||
1147514513 | 11475145 | 4 | 20150625 | 0 | ||
1147514513 | 11475145 | 5 | 20150903 | 0 | ||
1147514513 | 11475145 | 6 | 20120807 | 20120821 | 0 | |
1147514513 | 11475145 | 15 | 20120821 | 20120821 | 0 | |
1147514513 | 11475145 | 16 | 20120821 | 20120821 | 0 | |
1147514513 | 11475145 | 17 | 20120821 | 20120821 | 0 | |
1147514513 | 11475145 | 18 | 20120807 | 20120821 | 0 | |
1147514513 | 11475145 | 19 | 20120807 | 20120821 | 0 | |
1147514513 | 11475145 | 20 | 20120807 | 20120821 | 0 |